# Innate Pharma SA: Form SCHEDULE 13D/A, filed May 7, 2025

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: SCHEDULE 13D/A
- Filed: 2025-05-07
- Accepted by EDGAR: May 7, 2025, 16:02 ET
- Period: not reported
- Accession: 0001104659-25-045516
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000110465925045516/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000110465925045516/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000110465925045516/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-045516. Last ingested by Listed: Nov 5, 2026, 11:30 ET. No prices; not investment advice.